This study included 44 prostate cancer patients with adrenal lesions detected on [68Ga]Ga-PSMA PET/CT, comprising 16 patients (36.4%) with benign adrenal adenomas and 28 patients (63.6%) with adrenal metastases. This evidence concerns the gene FOLH1 and prostate cancer.